PCBL Chemical Limited has informed the Exchange about Transcript
PCBL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PCBL Chemical reported a steady Q1 FY26 with consolidated revenue of INR 2,114 crores, EBITDA of INR 325 crores (up ~2.5% QoQ), PBT of INR 120 crores and PAT of INR 94 crores. Carbon Black sales volume rose 2.6% QoQ to 1,54,093 MT with capacity utilisation above 97%, yielding an EBITDA per ton of INR 17,791. Aquapharm revenue was INR 382 crores with EBITDA of INR 50 crores; management reaffirmed its full-year Aquapharm EBITDA guidance of INR 300 crores. Management highlighted a major global competitor (Orion) planning to shut 2-5 plants (around 250,000-300,000 tons) in Europe and the US by year-end, which is seen as a structural opportunity for PCBL to gain global share. The company also announced a US patent for next-gen battery nanomaterials, completion of Acetylene Black technology transfer (India's first), Brownfield expansion of 30,000 MTPA in Tamil Nadu now in trial runs, and ongoing work to reach over 1 million tons of total capacity by FY28.
Shareholders can view this as a stable quarter with growth runway intact: capacity expansions in Carbon Black, Acetylene Black and Nanovace should drive both volume and margin expansion over the next 2-3 years, while global competitor closures create a structural tailwind. Near-term stock reaction may be muted as management declined specific margin guidance and flagged pricing pressure from dumping and tariff uncertainty.